跳至主要内容
临床试验/NCT00195611
NCT00195611已完成不适用

Observational Study of the Rhinopharyngeal Carriage of Streptococcus Pneumoniae (Sp) in Infants With Acute Otitis Media (AOM)

Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 3,293 人开始时间: 2005年9月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3,293

研究概览

简要总结

The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
6 Months 至 24 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Infants aged from 6 to 24 months
  • Presenting with AOM (ear infection)
  • Patients must not have received any antibiotic therapy within the past 7 days.
  • Other inclusion applies.

排除标准

  • 未提供

研究者

发起方
Wyeth is now a wholly owned subsidiary of Pfizer
申办方类型
Industry

相似试验